Crohn's Disease?
New study treatments that may put you back in control.
The chronic inflammatory condition of the gastrointestinal (GI) tract that can cause physical irritation has several options on the market. But, we’re working on giving you new options. Learn about the cutting-edge study treatments being investigated in your neighborhood.
5-20%
of people with Crohn's or Ulcerative Colitis have a close family member with the disease.
780k
Americans are thought to have Crohn's disease.
~70%
of people with Crohn's may require surgery to remove a diseased portion of their intestines.
Crohn’s can be incredibly isolating - people don’t want to talk about digestive issues… People just don’t understand it.
Patient
15 years with Crohn's Disease
Early on, I just got mad and frustrated with Crohn's, but I was not going to let this illness stop me from doing what I wanted to do.
Patient
7 years with Crohn's Disease
Crohn's Disease Clinical Trials
Learn about the newest Crohn's Disease study treatments now being investigated, including cutting-edge options available to clinical trial participants.
TrialSpark is now recruiting for a trial that tests the effectiveness of a new study treatment for Crohn's Disease.
Crohn's Disease In the News
From the latest relevant research and Crohn's Disease expert interviews to personal stories and advice on managing your symptoms, here’s everything about Crohn's Disease that’s making headlines.
Eli Lilly's Drug Candidate for Crohn's Diseases Moving into Phase III
Data from the phase II study showed significant reductions in clinical and endoscopic measures of disease activity at 12 weeks compared to placebo. Eli Lilly plans to begin phase III studies later this year, and this treatment (mirikizumab) is already being evaluated in phase III studies in other immune diseases, psoriasis and ulcerative colitis.
Dear Dietician - What can I eat when I have Crohn’s disease?
A dietician provides advice and tips to an individual recently diagnosed with Crohn's Disease
Recent Study Reveals a Microbe's Molecular Role in Crohn's disease
Researchers at the Broad Institute, Massachusetts General Hospital (MGH), and Harvard Medical School (HMS) have now found that one bacterium, Ruminococcus gnavus, which is associated with Crohn's disease, releases a certain type of polysaccharide (or a chain of sugar molecules) that triggers an immune response.
Digital Care Coordination with GIs Helps Patients Stay Out of the Hospital
A new study has found that digital care coordination can reduce the annual medical cost for each person by $6,500, through reduced hospitalizations and outpatient visits.
FAQ
Whether you’re considering participating in a clinical trial or just looking for more information about Crohn's Disease, we want you to keep you informed about living with Crohn's, your treatment options, and the clinical trial process.
Treating Crohn's Disease
See allJoin a Crohn's Disease Community
Connect with others who have Crohn's Disease to discuss your symptoms, experiences, treatment options, and more.
Stay updated on Crohn's Disease
We'll keep you updated on new and emerging treatments.
See if you qualify for a trial
New study treatments are being developed and investigated that may help address your condition.
Updated June 2019